IMA vs LEN
ImageneBio, Inc. (IMA) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
LEN (LEN) common stock.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
LEN does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. LEN currently screens at market cap $0.
Not investment advice. Open the IMA and LEN stock pages for the full models.
Not investment advice.